HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation
- 20 December 2007
- Vol. 373 (1) , 85-97
- https://doi.org/10.1016/j.virol.2007.10.042
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The IRF family, revisitedBiochimie, 2007
- Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine DeaminationJournal of Virology, 2006
- Alpha Interferon Potently Enhances the Anti-Human Immunodeficiency Virus Type 1 Activity of APOBEC3G in Resting Primary CD4 T CellsJournal of Virology, 2006
- Reverse Genetic Generation of Recombinant Zaire Ebola Viruses Containing Disrupted IRF-3 Inhibitory Domains Results in Attenuated Virus Growth In Vitro and Higher Levels of IRF-3 Activation without Inhibiting Viral Transcription or ReplicationJournal of Virology, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006
- Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradationGenes & Development, 2004
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004
- Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF ComplexScience, 2003
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002
- Impact of Viral Infection on the Gene Expression Profiles of Proliferating Normal Human Peripheral Blood Mononuclear Cells Infected with HIV Type 1 RFAIDS Research and Human Retroviruses, 2002